David Moss | Chief Financial Officer |
RJ Tesi | Chief Executive Officer |
Mark Lowdell | Chief Scientific Officer |
Tom Shrader | BTIG |
Daniel Carlson | Tailwinds Research |
Good day and welcome to the INmune Bio First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note today's event is being recorded.
I would now like to turn the conference over to David Moss, Chief Financial Officer. Please go ahead sir.